Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Insiderhandel: President, Energy Vault Labs kauft Aktien von Energy Vault Holdings im Wert von 9858 USD (Insiderkauf) +++ ENERGY VAULT Aktie +3,44%

CENCORA Aktie

 >CENCORA Aktienkurs 
263.2 EUR    +1.0%    (Tradegate)
Ask: 262.85 EUR / 120 Stück
Bid: 261.9 EUR / 120 Stück
Tagesumsatz: 31 Stück
Realtime Kurs von 8 bis 22 Uhr!
CENCORA Aktie über LYNX handeln
>CENCORA Performance
1 Woche: +3,1%
1 Monat: +1,6%
3 Monate: -1,1%
6 Monate: +10,7%
1 Jahr: +18,4%
laufendes Jahr: +19,0%
>CENCORA Aktie
Name:  CENCORA DL-,01
Land:  USA
Sektor:  Handel
ISIN/ Wkn:  US03073E1055 / 766149
Symbol/ Ticker:  ABG (Frankfurt) / COR (NYSE)
Kürzel:  FRA:ABG, ETR:ABG, ABG:GR, NYSE:COR
Index:  S&P500
Webseite:  https://www.cencora.com/
Profil:  Cencora Inc., formerly known as AmerisourceBergen ..
>Volltext..
Marktkapitalisierung:  49034.96 Mio. EUR
Unternehmenswert:  54290.26 Mio. EUR
Umsatz:  271749.18 Mio. EUR
EBITDA:  3897.3 Mio. EUR
Nettogewinn:  1628.2 Mio. EUR
Gewinn je Aktie:  8.4 EUR
Schulden:  7071.89 Mio. EUR
Liquide Mittel:  1952.66 Mio. EUR
Operativer Cashflow:  1495.03 Mio. EUR
Bargeldquote:  0.04
Umsatzwachstum:  1.44%
Gewinnwachstum:  -7.07%
Dividende je Aktie:  0.74 EUR
Dividendenrendite:  0.73%
Dividendenschätzung:  0.75%
Div. Historie:  09.06.25 - 0.183708€
10.03.25 - 0.18406€
>weitere anzeigen...
Insiderhandel:  2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 11.413.556 USD.
Suchwörter:  CENCORA, AMERISOURCEBERGEN
Letzte Datenerhebung:  21.08.25
>CENCORA Kennzahlen
Aktien/ Unternehmen:
Aktien: 193.88 Mio. St.
Frei handelbar: 99.63%
Rückkaufquote: 1.6%
Mitarbeiter: 46000
Umsatz/Mitarb.: 5.48 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 11.11%
Bewertung:
KGV: 31.54
KGV lG: 19.02
KUV: 0.18
KBV: 30.01
PEG-Ratio: 5.48
EV/EBITDA: 13.93
Rentabilität:
Bruttomarge: 3.06%
Gewinnmarge: 0.6%
Operative Marge: 1.09%
Managementeffizenz:
Gesamtkaprendite: 2.7%
Eigenkaprendite: 130.6%
>CENCORA Peer Group

Es sind 175 Aktien bekannt.
 
21.08.25 - 02:01
Insiderhandel: President & CEO verkauft Aktien von Cencora im Wert von 1458257 USD (Insiderkauf)
 
Mauch, Robert P. - Vorstand - Tag der Transaktion: 2025-08-18...
21.08.25 - 02:01
Insiderhandel: Executive Chairman verkauft Aktien von Cencora im Wert von 4227618 USD (Insiderkauf)
 
Collis, Steven H. - Vorstand - Tag der Transaktion: 2025-08-19...
16.08.25 - 15:15
Cencora directors ink $111M deal related to opioid claims (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
13.08.25 - 23:42
XFRA: DIVIDEND/INTEREST INFORMATION - 15.08.2025 - US03073E1055 (XETRA)
 
Das Instrument ABG US03073E1055 CENCORA DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am 14.08.2025 und ex Dividende/Zinsen am 15.08.2025 The instrument ABG US03073E1055 CENCORA DL-,01 EQUITY has its pre-dividend/interest day on 14.08.2025 and its ex-dividend/interest day on 15.08.2025...
13.08.25 - 15:54
Cencora Stock: Analyst Estimates & Ratings (Barchart)
 
Cencora has outpaced the broader market over the past year, and Wall Street analysts maintain a highly optimistic outlook on the stock's prospects....
11.08.25 - 20:30
3 Reasons Growth Investors Will Love Cencora (COR) (Zacks)
 
Cencora (COR) is well positioned to outperform the market, as it exhibits above-average growth in financials....
06.08.25 - 20:31
Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook (Benzinga)
 
Cencora reports Q3 sales of $80.66 billion and EPS of $4.00, both above estimates, driven by GLP-1 and specialty drug demand in U.S. markets. read more...
06.08.25 - 18:30
COR Q3 Earnings & Revenues Beat Estimates, ′25 EPS View Raised (Zacks)
 
Cencora posts strong Q3 results with earnings and revenues surpassing estimates; raises FY25 EPS guidance on robust U.S. segment growth....
06.08.25 - 18:30
Cencora raises 2025 EPS guidance to $15.85–$16 and narrows outlook as specialty drives growth (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.08.25 - 16:30
Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
 
The headline numbers for Cencora (COR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....
06.08.25 - 15:30
Cencora (COR) Q3 Earnings and Revenues Surpass Estimates (Zacks)
 
Cencora (COR) delivered earnings and revenue surprises of +5.82% and +0.41%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...
06.08.25 - 13:18
Cencora, Inc. Q3 Profit Increases, Beats Estimates (AFX)
 
WASHINGTON (dpa-AFX) - Cencora, Inc. (COR) released earnings for its third quarter that Increased from the same period last year and beat the Street estimates.The company's earnings came in at $68......
06.08.25 - 12:39
Cencora Non-GAAP EPS of $4.00 beats by $0.16, revenue of $80.66B beats by $540M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.08.25 - 12:33
Cencora Reports Fiscal 2025 Third Quarter Results (Business Wire)
 
Revenue of $80.7 billion for the Third Quarter, an 8.7 percent Increase Year-Over-Year Third Quarter GAAP Diluted EPS of $3.52 and Adjusted Diluted EPS of $4.00 Adjusted Diluted EPS Guidance Range Raised to $15.85 to $16.00 for Fiscal 2025CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 third quarter ended June 30, 2025, revenue increased 8.7 percent year-over-year to $80.7 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $3.52 for the third quarter of fiscal 2025 compared to $2.42 in the prior year third quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described below, increased 19.8 percent to $4.00 in the fiscal third quarter from $3.34 in the prior year third quarter. Cencora is updating its outlook for fiscal year 2025. The Company does not provide forward-looking guidance on a GAAP basis as discussed below in Fiscal Year 2025 Expectations. Adju...
06.08.25 - 11:09
RxPR: Podcasting Impact: Unprecedented Press Coverage of All Three National Drug Wholesaler Conferences Supporting Independent Pharmacy (Accesswire)
 
First podcast dedicated to the profession of pharmacy covers McKesson, Cencora, and Cardinal Health events BROWNSVILLE PA / ACCESS Newswire / August 6, 2025 / RxPR, LLC is proud to announce that th......
05.08.25 - 18:45
Cencora Q3 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.08.25 - 19:45
Can Specialty and GLP-1 Momentum Support Cencora′s Q3 Results? (Zacks)
 
COR benefits from strong specialty and GLP-1 demand, but Q3 results may face pressure from international weakness....
04.08.25 - 14:03
Mallinckrodt Names Leslie Donato to Board of Directors (PR Newswire)
 
Appointment of Former Cencora Executive Completes Nine-Member Board DUBLIN, Aug. 4, 2025 /PRNewswire/ -- Mallinckrodt plc today announced that Leslie Donato has been appointed to the Company's Board of Directors, bringing the board's composition to a total of nine members. An accomplished......
29.07.25 - 14:42
Labor Smart, Inc.: LTNC′s LOCK′DIN Partners with Fortune 10 Leader Cencora; Portion of Proceeds to Benefit Manny Pacquiao Foundation (Accesswire)
 
JACKSON, WY / ACCESS Newswire / July 29, 2025 / Labor Smart, Inc. (OTCID:LTNC), a Wyoming-based publicly traded company, today announced a landmark partnership for its functional hydration brand LO......
24.07.25 - 01:01
Insiderhandel: Executive Chairman verkauft Aktien von Cencora im Wert von 4266543 USD (Insiderkauf)
 
Collis, Steven H. - Vorstand - Tag der Transaktion: 2025-07-22...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Nur übereilt bestimmt die Neigung sich. - Johann Wolfgang von Goethe
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!